The Relative Strength (RS) Rating for Establishment Labs Hldgs entered a new percentile Wednesday, with an increase from 77 to 81.
Hone Your Stock-Picking Skills By Focusing On These Factors
This unique rating tracks technical performance by using a 1 (worst) to 99 (best) score that indicates how a stock's price performance over the trailing 52 weeks matches up against that of all other stocks.
Decades of market research reveals that the best stocks typically have an RS Rating of above 80 in the early stages of their moves.
Establishment Labs Hldgs is not currently offering a proper buying opportunity. See if the stock goes on to build a promising consolidation that could kick off a new climb.
The company reported 0% earnings growth in the latest quarterly report. Revenue increased 11%.
Establishment Labs Hldgs holds the No. 52 rank among its peers in the Medical-Products industry group. Insulet, Boston Scientific and ResMed are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Price Performance?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
